Ronald R Taylor insider trades

Open-market stock purchases and sales by Ronald R Taylor, Director at Resmed Inc, from SEC Form 4 filings since Jan 20, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +256%.

Recent trades

DateStockTradeValue
Nov 20, 2025RMD Resmed IncBought (not open market)—

Companies traded

  • RMD Resmed Inc: 1 buy, 10 sales, last Nov 20, 2025
  • AGN Allergan plc: other filings, last May 4, 2017
  • ACT Actavis plc: 2 sales, last Jun 5, 2015
  • RLH Red Lion Hotels Corp: other filings, last Jan 6, 2014
  • WPI Watson Pharmaceuticals Inc: 1 sale, last May 30, 2012

Get free alerts when Ronald R Taylor files a new trade →